Increased kynurenic acid production has been implicated in the pathology of schizophrenia. The findings provide a new target for cell-specific treatments that help reduce the production of kynurenic acid and reduce symptoms of schizophrenia.![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_skh-dThjk02JoEanqfsCveDApIL6jLIWQ0eVEMqMak_q_rxYV-al7W299aeNfc-9-QWhXgHV31t8R7NrfiotazoWlq4Zf7rG2g7CMgML-doGBedysxL85wd61V6t6y-FK1qjbv7rKG0zPGDrgCRSuu_ABIMOBBqQyU=s0-d)
from Neuroscience News Updates http://bit.ly/2IrjNpN
from Neuroscience News Updates http://bit.ly/2IrjNpN
Comments
Post a Comment